It is undeniable that the Food and Drug Administration (FDA) has been tightening its safety strings lately. Last year they approved only 19 new medicines (the lowest number in nearly a quarter century) and put out twice as many new or revised “black-box” warnings for severe side effects as in 2006.
          Whereas consumers may appreciate the FDA’s new burst of caution, drug manufacturers such as Shering-Plough Corp and Merck are pining over lost profits. Company executives are now complaining that it takes longer to get drugs approved now that the FDA is demanding more data, and that even then approval is not guaranteed.
          This crackdown on drug safety has come amid several defective drug scandals, including those of Vioxx, Avandia, Vytorin, Heparin and Chantix. Several of these drugs were approved despite evidence that they may cause serious harm, and others were approved without sufficient testing.

          The defective drug lawyers at Cappolino Dodd Krebs LLP are committed to helping you get compensation you deserve from negligent drug manufacturers when you have been harmed by their products. If you have been harmed by a drug you believe to be dangerous or defective, contact Cappolino Dodd Krebs LLP at 1-800-460-0606 as soon as possible.

This entry was posted on Monday, July 28th, 2008 at 4:41 pm and is filed under Defective Drugs, Safety. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.